Biota Pharmaceuticals
- Biological Products, Except Diagnostic Substances
- South San Francisco, California
Compensation history
Top executives at Biota Pharmaceuticals received an average of $1M per person in annual compensation from 2006 to 2023.
By year
Executives
We found 19 executives who work or worked at Biota Pharmaceuticals.
Andrei Floroiu
Biota Pharmaceuticals
Chief Executive Officer
Sean Tucker
Biota Pharmaceuticals
Chief Scientific Officer
James Cummings
Biota Pharmaceuticals
Chief Medical Officer
Wouter Latour
Biota Pharmaceuticals
Chief Executive Officer
Margaret Echerd
Biota Pharmaceuticals
SVP Controller and Principal Accounting Officer
John Harland
Biota Pharmaceuticals
Chief Financial Officer
Joseph Patti
Biota Pharmaceuticals
Chief Executive Officer
Mark Colonnese
Biota Pharmaceuticals
Chief Financial Officer
News
Biota Pharmaceuticals CEO Andrei Floroiu's 2023 pay falls 48% to $1.9M
April 29, 2024
Biota Pharmaceuticals CEO Andrei Floroiu's 2022 pay jumps 49% to $3.6M
April 28, 2023
Biota Pharmaceuticals CEO Wouter Latour's 2020 pay jumps 280% to $2.8M
April 30, 2021
Biota Pharmaceuticals CEO Wouter Latour's 2019 pay slips 12% to $748K
April 24, 2020
Biota Pharmaceuticals CEO Joseph Patti's 2018 pay rises 12% to $1.2M
March 11, 2019
About Biota Pharmaceuticals
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Biological Products, Except Diagnostic Substances
- 170 Harbor Way, Suite 300, South San Francisco, California 94080
- (650) 550-3500
- December 31
- Former names
- Aviragen Therapeutics, Inc.
- Biota Pharmaceuticals, Inc.
- NABI BIOPHARMACEUTICALS
- NABI BIOPHARMACEUTICALS
- NABI /DE/
- NORTH AMERICAN BIOLOGICALS INC